3,192 Shares in Chemed Corporation $CHE Acquired by Intech Investment Management LLC

Intech Investment Management LLC purchased a new position in Chemed Corporation (NYSE:CHE) during the 3rd quarter, Holdings Channel reports. The fund purchased 3,192 shares of the company’s stock, valued at approximately $1,429,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Geneos Wealth Management Inc. raised its holdings in Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the period. First Horizon Advisors Inc. grew its holdings in Chemed by 16.8% during the second quarter. First Horizon Advisors Inc. now owns 202 shares of the company’s stock valued at $99,000 after purchasing an additional 29 shares during the period. Savant Capital LLC purchased a new stake in Chemed in the second quarter worth about $378,000. AGF Management Ltd. purchased a new stake in Chemed in the second quarter worth about $2,432,000. Finally, Parkside Financial Bank & Trust raised its stake in shares of Chemed by 86.3% in the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after buying an additional 44 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of CHE opened at $408.06 on Friday. The stock has a market capitalization of $5.62 billion, a price-to-earnings ratio of 22.21, a price-to-earnings-growth ratio of 1.63 and a beta of 0.46. Chemed Corporation has a 1 year low of $385.00 and a 1 year high of $623.60. The business’s 50 day simple moving average is $444.21 and its 200-day simple moving average is $442.86.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The business had revenue of $639.34 million during the quarter, compared to analysts’ expectations of $659.09 million. During the same period last year, the business posted $6.83 earnings per share. The company’s revenue for the quarter was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, sell-side analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is presently 13.06%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CHE. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Oppenheimer dropped their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $498.00.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.